OrthoPediatrics (NASDAQ:KIDS) Shares Gap Down on Analyst Downgrade

OrthoPediatrics Corp. (NASDAQ:KIDS) gapped down prior to trading on Wednesday after Stifel Nicolaus lowered their price target on the stock from $40.00 to $32.00. The stock had previously closed at $22.89, but opened at $22.28. Stifel Nicolaus currently has a buy rating on the stock. OrthoPediatrics shares last traded at $23.69, with a volume of 12,976 shares.

Other equities analysts have also recently issued research reports about the stock. Needham & Company LLC restated a “buy” rating and issued a $42.00 price objective on shares of OrthoPediatrics in a research report on Wednesday. Truist Financial reduced their price target on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th.

Institutional Investors Weigh In On OrthoPediatrics

Institutional investors and hedge funds have recently modified their holdings of the stock. Quarry LP purchased a new position in shares of OrthoPediatrics during the third quarter valued at about $25,000. International Assets Investment Management LLC grew its holdings in shares of OrthoPediatrics by 2,610.8% during the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock worth $27,000 after acquiring an additional 966 shares during the period. R Squared Ltd bought a new position in shares of OrthoPediatrics in the 4th quarter worth approximately $48,000. KLP Kapitalforvaltning AS purchased a new position in shares of OrthoPediatrics in the 4th quarter valued at approximately $79,000. Finally, BNP Paribas Financial Markets boosted its position in shares of OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock valued at $94,000 after purchasing an additional 1,929 shares in the last quarter. 69.05% of the stock is owned by hedge funds and other institutional investors.

OrthoPediatrics Stock Performance

The company has a 50 day moving average of $24.39 and a two-hundred day moving average of $25.94. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. The company has a market capitalization of $620.17 million, a PE ratio of -20.82 and a beta of 1.14.

OrthoPediatrics (NASDAQ:KIDS) last released its earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The firm had revenue of $52.67 million for the quarter, compared to the consensus estimate of $51.16 million. During the same period in the prior year, the firm earned ($0.23) EPS. As a group, equities research analysts predict that OrthoPediatrics Corp. will post -0.93 earnings per share for the current year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.